Role of genetic and epigenetic changes in Burkitt lymphoma.
about
T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma linesPotential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr VirusThe IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesisDenis Burkitt and the African lymphomaEpigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.Latent Epstein-Barr virus can inhibit apoptosis in B cells by blocking the induction of NOXA expressionSpecific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.Myc overexpression brings out unexpected antiapoptotic effects of miR-34aAn anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas.Novel therapeutics for aggressive non-Hodgkin's lymphoma.Toward a genetics of cancer resistance.c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?The molecular background of aggressive B cell lymphomas as a basis for targeted therapy.Cumulative Epigenetic Abnormalities in Host Genes with Viral and Microbial Infection during Initiation and Progression of Malignant Lymphoma/Leukemia.Epstein-Barr virus and Burkitt lymphoma.Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis.Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition.DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphomaActivation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells.Omomyc expression in skin prevents Myc-induced papillomatosis.Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children.EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases.Epstein-Barr virus-associated lymphomas
P2860
Q24681203-740E4EF7-E9AE-45C0-851B-DEC2071618FDQ26852071-0E2ADDEF-23E5-4E29-A3C6-002EEDEEB9ECQ28075599-7EA3E709-8F0A-4106-B38F-E3B16A4BE39BQ28742252-C6DF70F1-4C3C-4C1F-B7F2-8181AAA32B48Q33604848-C5368BB1-9B44-47AB-BC6A-FA4BCE01D15EQ33716529-B316B19E-E548-4E00-AACA-49BF6BE22749Q34103135-7A6D20AF-B8DA-48C6-BF6B-BABFA3E2BBC4Q34334050-09514EE1-6FA5-4C0B-819C-6385A73AE0DAQ34658852-F2A08BCE-BF68-4C02-B6AC-141376CB19D2Q35084362-C4E74EE5-D90C-40DF-8F5B-416A22370168Q35096060-A73C283F-7110-4379-8DAA-C7F5480C4919Q35111768-AFD8A2EA-33E0-4B0B-BFBB-ABC97289B601Q37070576-16405FF0-C0C9-4C94-997D-1E0B400FE2C4Q37192244-633E0869-9410-4DCE-B33E-75EA252B3BF4Q37563700-E4BB8C50-9709-496F-B1DD-456262B0501EQ37815142-65BC1095-4C20-4261-BB34-8BDACF9E35F9Q38161335-69172DB1-373C-40A8-A4FE-4F25A6AA6BF8Q38270680-4CC0EF03-EF4B-48D7-B81B-216D936C0F6DQ38798819-0B2EAB44-7066-4640-9176-83698FB70747Q39396721-B2172801-FC15-467C-9364-A546442F34E8Q39692513-C3AC254F-F6C0-4139-AE9D-CB1D59466BC8Q39855621-8E202088-77C7-4340-ADBF-75578D97C177Q40555942-3FA19374-9AA6-471A-98B5-1905675F0798Q46125111-90521471-A9F2-4EA4-826D-3BECE108C631Q47277659-90915237-086F-421F-9B10-C71F73D135C8Q51735191-089D808E-984D-42B8-B3A3-E22792828553Q52628104-631C42BD-BBF1-41D8-948D-BB28FCB11B4EQ56930876-8913D8F8-FCD1-4362-BED4-D42AB038767E
P2860
Role of genetic and epigenetic changes in Burkitt lymphoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Role of genetic and epigenetic changes in Burkitt lymphoma.
@ast
Role of genetic and epigenetic changes in Burkitt lymphoma.
@en
Role of genetic and epigenetic changes in Burkitt lymphoma.
@nl
type
label
Role of genetic and epigenetic changes in Burkitt lymphoma.
@ast
Role of genetic and epigenetic changes in Burkitt lymphoma.
@en
Role of genetic and epigenetic changes in Burkitt lymphoma.
@nl
prefLabel
Role of genetic and epigenetic changes in Burkitt lymphoma.
@ast
Role of genetic and epigenetic changes in Burkitt lymphoma.
@en
Role of genetic and epigenetic changes in Burkitt lymphoma.
@nl
P1476
Role of genetic and epigenetic changes in Burkitt lymphoma.
@en
P2093
Klas G Wiman
Mikael S Lindström
P304
P356
10.1016/S1044-579X(02)00058-5
P577
2002-10-01T00:00:00Z